Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07648420 · ClinicalTrials.gov registry record · NA
Using Apollo Neuro in Autistic Children With Self-Injurious Behavior
A NA study, sponsored by Virginia Commonwealth University.
- Not yet
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT07648420 is a NA study that has not yet begun recruiting, run by Virginia Commonwealth University. The registered enrollment target is 18 participants.
The verdict
NCT07648420, a NA study, has not yet begun recruiting, sponsored by Virginia Commonwealth University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study will evaluate the feasibility and acceptability of the Apollo Neuro, a wearable vibrotactile sensory device, in autistic children who engage in self-injurious behavior (SIB). Participants will wear the device for at least 3 hours per day over a 30-35 day period with caregiver support. Outcomes will include adherence to device use, caregiver-reported feasibility and acceptability, and descriptive characterization of caregiver-reported self- injurious and repetitive behaviors during the study period. This preliminary, single-group study is not designed to evaluate efficacy and will inform the design of future controlled trials.
Interventions
- DEVICE Apollo Neuro device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2026-07 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07648420
The ClinicalTrials.gov registry entry for NCT07648420 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Apollo Neuro device is the first listed.
NCT07648420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07648420 about?
NCT07648420 is a clinical study titled "Using Apollo Neuro in Autistic Children With Self-Injurious Behavior". This study will evaluate the feasibility and acceptability of the Apollo Neuro, a wearable vibrotactile sensory device, in autistic children who engage in self-injurious behavior (SIB). Participants will wear the device for at least 3 hours per day over a 30-35 day period with caregiver support. Ou...
What is the current status of trial NCT07648420?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2026-07. Estimated completion is 2026-11.
What interventions are being tested in trial NCT07648420?
The interventions under investigation include: Apollo Neuro device (DEVICE).
Who is sponsoring clinical trial NCT07648420?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.